Lawrence G. Lum

7.5k citations

212 papers · 4.7k indexed · h-index 39

Immunology top 1%
- Immunotherapy and Immune Responses 50
- Immune Cell Function and Interaction 33
- T-cell and B-cell Immunology 27
Hematology top 1%
- Hematopoietic Stem Cell Transplantation 52
- Multiple Myeloma Research and Treatments 11
Oncology top 1%
- CAR-T cell therapy research 80
- Cancer Immunotherapy and Biomarkers 22
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research 61
Genetics top 5%

Co-authors: Archana Thakur Abhinav Deol Werner J. Pichler Samuel Broder Rainer Storb Pamela A. Davol R. Michael Blaese Joseph P. Uberti
Cited by: Immunology Hematology Oncology
Journals: New England Journal of Medicine (2 papers)Journal of Clinical Oncology (12 papers)SHILAP Revista de lepidopterología (1 paper)
Partner nations: United States Canada South Africa

In The Last Decade

Lawrence G. Lum

207 papers receiving 4.5k citations

Peers

Countries citing papers authored by Lawrence G. Lum

Since Specialization

Citations

This map shows the geographic impact of Lawrence G. Lum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence G. Lum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence G. Lum more than expected).

Fields of papers citing papers by Lawrence G. Lum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence G. Lum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence G. Lum. The network helps show where Lawrence G. Lum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lawrence G. Lum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence G. Lum Line = papers co-authored together Lawrence G. Lum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T Cancer Research Communications ·Michael C. Brown,Vincent M. D’Anniballe,David Boczkowski,Harini Kandadi,Nadeem A. Sheikh,William Kornahrens,Elisabeth I. Heath,Archana Thakur,Wei Chen,Lawrence G. Lum,Frank C. Cackowski,Julie L. Boerner,Michael D. Gunn,Andrew J. Armstrong,Smita K. Nair	2024	3
2	Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate–Resistant Prostate Cancer Cancer Research Communications ·Elisabeth I. Heath,Archana Thakur,Wei Chen,Clara Hwang,Channing J. Paller,Frank C. Cackowski,Julie L. Boerner,Lance K. Heilbrun,Melanie P. Smith,Dana L. Schalk,Amy Schienschang,Sarah A. Whitaker,Amanda Polend,Daryn Smith,Ulka N. Vaishampayan,Brenda Dickow,Lawrence G. Lum	2024	3
3	Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Ulka N. Vaishampayan,Archana Thakur,Wei Chen,Abhinav Deol,Meera Patel,Kimberlee Dobson,Brenda Dickow,Dana L. Schalk,Amy Schienschang,Sarah A. Whitaker,Amanda Polend,Joseph A. Fontana,Elisabeth I. Heath,Lawrence G. Lum	2022	21
4	Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells Frontiers in Immunology ·Archana Thakur,John Scholler,Ewa Kubicka,Edwin T. Bliemeister,Dana L. Schalk,Carl H. June,Lawrence G. Lum	2021	13
5	Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study Journal of Cancer Research and Clinical Oncology ·Archana Thakur,John Scholler,Dana L. Schalk,Carl H. June,Lawrence G. Lum	2020	14
6	Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis Cancer Research ·Shasha Ruan,Ming Lin,Yong Xia Zhu,Lawrence G. Lum,Archana Thakur,Runming Jin,Wenlong Shao,Yalei Zhang,Yangyang Hu,Shiang Huang,Elaine M. Hurt,Alfred E. Chang,Max S. Wicha,Qiao Li	2019	60
7	Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial Clinical Cancer Research ·Lawrence G. Lum,Archana Thakur,Zaid Al‐Kadhimi,Gerald A. Colvin,F J Cummings,Robert D. Legare,Don S. Dizon,Nicola Kouttab,Abby Maizel,William Colaiace,Qin Liu,Ritesh Rathore	2015	87
8	Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination Cancer Immunology Research ·Heather M. Gibson,Jesse Veenstra,Richard Jones,Ulka N. Vaishampayan,Michele Sauerbrey,Gerold Bepler,Lawrence G. Lum,Joyce Reyes,Amy Weise,Wei‐Zen Wei	2015	11
9	Anti‐CD3 × anti‐GD2 bispecific antibody redirects T‐cell cytolytic activity to neuroblastoma targets Pediatric Blood & Cancer ·Maxim Yankelevich,Sri Vidya Kondadasula,Archana Thakur,Steven Buck,Nai‐Kong V. Cheung,Lawrence G. Lum	2012	61
10	A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function Biology of Blood and Marrow Transplantation ·Muneer H. Abidi,Rishi Agarwal,Nishant Tageja,Lois Ayash,Abhinav Deol,Zaid Al‐Kadhimi,Judith Abrams,Simon Cronin,Marie Ventimiglia,Lawrence G. Lum,Voravit Ratanatharathorn,Jeffrey A. Zonder,Joseph P. Uberti	2012	17
11	Scutellaria extract and wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-β1 activity Cancer Immunology Immunotherapy ·Sagar Dandawate,Linford Williams,Nirmal Joshee,Agnes M. Rimando,Sandeep Mittal,Archana Thakur,Lawrence G. Lum,Prahlad Parajuli	2011	36
12	Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I). Blood ·Lawrence G. Lum,Ritesh Rathore,Don S. Dizon,Ding Wang,Zaid Al‐Kadhimi,Joseph P. Uberti,Voravit Ratanatharathorn	2007	3
13	Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation Clinical Cancer Research ·Ryan C. Grabert,Leslie P. Cousens,Janelle A. Smith,Sarah D. Olson,Jonathan M. Gall,Wendy B. Young,Pamela A. Davol,Lawrence G. Lum	2006	63
14	Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas. PubMed ·Hillary E. Lum,Mendy Miller,Pamela A. Davol,Ryan C. Grabert,James B. Davis,Lawrence G. Lum	2005	14
15	The haploimmunostorm syndrome: A distinct clinical entity seen in HLA-mismatched cellular immunotherapy Biology of Blood and Marrow Transplantation ·Gerald A. Colvin,Ritesh Rathore,Lawrence G. Lum,Mehrdad Abedi,Karen K. Ballen,Bimal Dey,Gerald J. Elfenbein,Peter J. Quesenberry	2005	1
16	How Important Is HER2/neu Amplification and Expression when Selecting Patients for HER2/neu–Targeted Therapies? Clinical Breast Cancer ·Pamela A. Davol,Lawrence G. Lum	2004	2
17	Phase I/II Study of Treatment of Stage IV Breast Cancer with OKT3 x Trastuzumab–Armed Activated T Cells Clinical Breast Cancer ·Lawrence G. Lum,Ritesh Rathore,Frank J. Cummings,Gerald A. Colvin,Kathy Radie-Keane,Abby Maizel,Peter J. Quesenberry,Gerald J. Elfenbein	2003	16
18	Use of Anti-CD3 × Anti-HER2/neu Bispecific Antibody for Redirecting Cytotoxicity of Activated T Cells Toward HER2/neu ⁺ Tumors Journal of Hematotherapy & Stem Cell Research ·Manjula Sen,D. M. Wankowski,Nina Garlie,Ruth E. Siebenlist,Dennis Van Epps,Ann V. LeFever,Lawrence G. Lum	2001	80
19	Recapitulation of immune ontogeny: A vital component for the success of bone marrow transplantation Cancer treatment and research ·Lawrence G. Lum	1990	6
20	Chronic lymphocytosis with neutropenia: Evidence for a novel, abnormal T-cell population associated with antibody-mediated neutrophil destruction Clinical Immunology and Immunopathology ·Gordon Starkebaum,Paul J. Martin,Jack W. Singer,Lawrence G. Lum,Thomas H. Price,Marshall E. Kadin,Wendy H. Raskind,Philip J. Fialkow	1983	40

About Lawrence G. Lum

Lawrence G. Lum is a scholar working on Hematology, Immunology and Oncology, having authored 212 papers that have together received 4.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (80 papers), Monoclonal and Polyclonal Antibodies Research (61 papers), Hematopoietic Stem Cell Transplantation (52 papers), Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (33 papers), T-cell and B-cell Immunology (27 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Multiple Myeloma Research and Treatments (11 papers). The work is most often cited by research in Immunology (2.2k citations), Hematology (971 citations) and Oncology (1.9k citations). Lawrence G. Lum has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Archana Thakur, Abhinav Deol, Werner J. Pichler, Samuel Broder, Rainer Storb, Pamela A. Davol, R. Michael Blaese, Joseph P. Uberti, Manley Huang and Dana L. Schalk. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact